Aerpio Therapeutics, Inc. — Form D

Aerpio Therapeutics, Inc. of CINCINNATI, OH, a company, filed a Form D exempt-offering notice with the SEC on 2012-11-16. The offering totals $21.9M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Anupam AW DalalDirectorCincinnati, OH
Adrienne AW GravesDirectorCincinnati, OH
Campbell AW MurrayDirectorCincinnati, OH
John AW RiceDirectorCincinnati, OH
Paul AW WeissDirectorCincinnati, OH
Ian AW HowesExecutive OfficerSeattle, WA
Kevin AW PetersExecutive OfficerCincinnati, OH
Robert AW ShalwitzExecutive OfficerCincinnati, OH
John H RiceDirectorBethesda, MD
Joseph H GardnerDirectorCincinnati, OH
Joseph H GardnerExecutive OfficerCincinnati, OH
Paul H WeissDirectorCincinnati, OH
Campbell H MurrayDirectorCincinnati, OH
Duane H NashDirectorCincinnati, OH
Steve H PakolaExecutive OfficerCincinnati, OH
Reinhard H AmbrosDirectorCincinnati, OH
Anupam H DalalDirectorCincinnati, OH
Chau H KhuongDirectorCincinnati, OH
Adrienne H GravesDirectorCincinnati, OH
Kevin H PetersExecutive OfficerCincinnati, OH
Muneer H SatterDirectorCincinnati, OH
Lauren H SilvermanDirectorCincinnati, OH
Robert H ShalwitzExecutive OfficerCincinnati, OH
William H DalyExecutive OfficerCincinnati, OH
Alan H FishmanExecutive OfficerCincinnati, OH

Other filings by this issuer (6)

FiledFormOfferingSold
2016-11-14D$4.6M$3.5M
2016-04-15D$9.2M$4.5M
2014-05-06D$22.0M$22.0M
2013-11-15D/A$31.0M$27.0M
2013-09-12D/A$21.9M$18.0M
2012-01-05D$5.0M$5.0M

More